La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study

Identifieur interne : 000C04 ( PascalFrancis/Corpus ); précédent : 000C03; suivant : 000C05

Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study

Auteurs : N. E. Maher ; L. I. Golbe ; A. M. Lazzarini ; M. H. Mark ; L. J. Currie ; G. F. Wooten ; M. Saint-Hilaire ; J. B. Wilk ; J. Volcjak ; J. E. Maher ; R. G. Feldman ; M. Guttman ; M. Lew ; S. Schuman ; O. Suchowersky ; A. L. Lafontaine ; N. Labelle ; P. Vieregge ; P. P. Pramstaller ; C. Klein ; J. Hubble ; C. Reider ; J. Growdon ; R. Watts ; E. Montgomery ; K. Baker ; C. Singer ; M. Stacy ; R. H. Myers

Source :

RBID : Pascal:02-0118878

Descripteurs français

English descriptors

Abstract

Objective: To examine patterns of familial aggregation and factors influencing onset age in a sample of siblings with PD. Methods: Sibling pairs (n = 203) with PD were collected as part of the GenePD study. Standardized family history, medical history, and risk factor data were collected and analyzed. Results: The mean age at onset was 61.4 years and did not differ according to sex, exposure to coffee, alcohol, or pesticides. Head trauma was associated with younger onset (p = 0.03) and multivitamin use with later onset (p = 0.007). Age at onset correlation between sibling pairs was significant (r = 0.56, p = 0.001) and was larger than the correlation in year of onset (r = 0.29). The mean difference in onset age between siblings was 8.7 years (range, 0 to 30 years). Female sex was associated with increased frequency of relatives with PD. The frequency of affected parents (7.0%) and siblings (5.1%) was increased when compared with frequency in spouses (2.0%). Conclusions: The greater similarity for age at onset than for year of onset in sibling pairs with PD, together with increased risk for biological relatives over spouses of cases, supports a genetic component for PD. Risk to siblings in this series is increased over that seen in random series of PD cases; however, patients in this sample have similar ages at onset and sex distribution as seen for PD generally. These analyses suggest that factors influencing penetrance are critical to the understanding of this disease.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0028-3878
A02 01      @0 NEURAI
A03   1    @0 Neurology
A05       @2 58
A06       @2 1
A08 01  1  ENG  @1 Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study
A11 01  1    @1 MAHER (N. E.)
A11 02  1    @1 GOLBE (L. I.)
A11 03  1    @1 LAZZARINI (A. M.)
A11 04  1    @1 MARK (M. H.)
A11 05  1    @1 CURRIE (L. J.)
A11 06  1    @1 WOOTEN (G. F.)
A11 07  1    @1 SAINT-HILAIRE (M.)
A11 08  1    @1 WILK (J. B.)
A11 09  1    @1 VOLCJAK (J.)
A11 10  1    @1 MAHER (J. E.)
A11 11  1    @1 FELDMAN (R. G.)
A11 12  1    @1 GUTTMAN (M.)
A11 13  1    @1 LEW (M.)
A11 14  1    @1 SCHUMAN (S.)
A11 15  1    @1 SUCHOWERSKY (O.)
A11 16  1    @1 LAFONTAINE (A. L.)
A11 17  1    @1 LABELLE (N.)
A11 18  1    @1 VIEREGGE (P.)
A11 19  1    @1 PRAMSTALLER (P. P.)
A11 20  1    @1 KLEIN (C.)
A11 21  1    @1 HUBBLE (J.)
A11 22  1    @1 REIDER (C.)
A11 23  1    @1 GROWDON (J.)
A11 24  1    @1 WATTS (R.)
A11 25  1    @1 MONTGOMERY (E.)
A11 26  1    @1 BAKER (K.)
A11 27  1    @1 SINGER (C.)
A11 28  1    @1 STACY (M.)
A11 29  1    @1 MYERS (R. H.)
A14 01      @1 Department of Neurology, Boston University School of Medicine @2 MA @3 USA
A14 02      @1 Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School @2 New Brunswick @3 USA
A14 03      @1 Department of Neurology, University of Virginia Health System @2 Charlottesville @3 USA
A14 04      @1 Division of Neurology, Department of Medicine, University of Toronto @2 Ontario @3 CAN
A14 05      @1 Department of Neurology, University of Southern California @2 Los Angeles @3 USA
A14 06      @1 Departments of Clinical Neurosciences and Medical Genetics, University of Calgary @2 Alberta @3 CAN
A14 07      @1 Department of Neurology, Medical University of Lübeck @3 DEU
A14 08      @1 Department of Neurology, General Regional Hospital Bolzano @3 ITA
A14 09      @1 Department of Neurology, Ohio State University @2 Columbus @3 USA
A14 10      @1 Department of Neurology Massachusetts General Hospital, Harvard Medical School @2 Boston @3 USA
A14 11      @1 Department of Neurology, Emory University @2 Atlanta, GA @3 USA
A14 12      @1 Departments of Neurology and Neuroscience, Cleveland Clinic Foundation @2 OH @3 USA
A14 13      @1 Department of Neurology, University of Miami @2 FL @3 USA
A14 14      @1 Department of Neurology, Barrow Clinic @2 Phoenix, AZ @3 USA
A20       @1 79-84
A21       @1 2002
A23 01      @0 ENG
A43 01      @1 INIST @2 6345 @5 354000094698500120
A44       @0 0000 @1 © 2002 INIST-CNRS. All rights reserved.
A45       @0 54 ref.
A47 01  1    @0 02-0118878
A60       @1 P
A61       @0 A
A64 01  1    @0 Neurology
A66 01      @0 USA
C01 01    ENG  @0 Objective: To examine patterns of familial aggregation and factors influencing onset age in a sample of siblings with PD. Methods: Sibling pairs (n = 203) with PD were collected as part of the GenePD study. Standardized family history, medical history, and risk factor data were collected and analyzed. Results: The mean age at onset was 61.4 years and did not differ according to sex, exposure to coffee, alcohol, or pesticides. Head trauma was associated with younger onset (p = 0.03) and multivitamin use with later onset (p = 0.007). Age at onset correlation between sibling pairs was significant (r = 0.56, p = 0.001) and was larger than the correlation in year of onset (r = 0.29). The mean difference in onset age between siblings was 8.7 years (range, 0 to 30 years). Female sex was associated with increased frequency of relatives with PD. The frequency of affected parents (7.0%) and siblings (5.1%) was increased when compared with frequency in spouses (2.0%). Conclusions: The greater similarity for age at onset than for year of onset in sibling pairs with PD, together with increased risk for biological relatives over spouses of cases, supports a genetic component for PD. Risk to siblings in this series is increased over that seen in random series of PD cases; however, patients in this sample have similar ages at onset and sex distribution as seen for PD generally. These analyses suggest that factors influencing penetrance are critical to the understanding of this disease.
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Parkinson maladie @5 01
C03 01  X  ENG  @0 Parkinson disease @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @5 01
C03 02  X  FRE  @0 Age apparition @5 04
C03 02  X  ENG  @0 Age of onset @5 04
C03 02  X  SPA  @0 Edad aparición @5 04
C03 03  X  FRE  @0 Agrégation @5 07
C03 03  X  ENG  @0 Aggregation @5 07
C03 03  X  SPA  @0 Agregación @5 07
C03 04  X  FRE  @0 Phénotype @5 10
C03 04  X  ENG  @0 Phenotype @5 10
C03 04  X  SPA  @0 Fenotipo @5 10
C03 05  X  FRE  @0 Déterminisme génétique @5 16
C03 05  X  ENG  @0 Genetic determinism @5 16
C03 05  X  SPA  @0 Determinismo genético @5 16
C03 06  X  FRE  @0 Epidémiologie @5 17
C03 06  X  ENG  @0 Epidemiology @5 17
C03 06  X  SPA  @0 Epidemiología @5 17
C03 07  X  FRE  @0 Fratrie @5 18
C03 07  X  ENG  @0 Sibling @5 18
C03 07  X  SPA  @0 Hermandad @5 18
C03 08  X  FRE  @0 Facteur risque @5 19
C03 08  X  ENG  @0 Risk factor @5 19
C03 08  X  SPA  @0 Factor riesgo @5 19
C03 09  X  FRE  @0 Homme @5 20
C03 09  X  ENG  @0 Human @5 20
C03 09  X  SPA  @0 Hombre @5 20
C07 01  X  FRE  @0 Système nerveux pathologie @5 37
C07 01  X  ENG  @0 Nervous system diseases @5 37
C07 01  X  SPA  @0 Sistema nervioso patología @5 37
C07 02  X  FRE  @0 Système nerveux central pathologie @5 38
C07 02  X  ENG  @0 Central nervous system disease @5 38
C07 02  X  SPA  @0 Sistema nervosio central patología @5 38
C07 03  X  FRE  @0 Encéphale pathologie @5 39
C07 03  X  ENG  @0 Cerebral disorder @5 39
C07 03  X  SPA  @0 Encéfalo patología @5 39
C07 04  X  FRE  @0 Extrapyramidal syndrome @5 40
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 40
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 40
C07 05  X  FRE  @0 Maladie dégénérative @5 41
C07 05  X  ENG  @0 Degenerative disease @5 41
C07 05  X  SPA  @0 Enfermedad degenerativa @5 41
C07 06  X  FRE  @0 Maladie héréditaire @5 42
C07 06  X  ENG  @0 Genetic disease @5 42
C07 06  X  SPA  @0 Enfermedad hereditaria @5 42
N21       @1 063
N82       @1 PSI

Format Inist (serveur)

NO : PASCAL 02-0118878 INIST
ET : Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study
AU : MAHER (N. E.); GOLBE (L. I.); LAZZARINI (A. M.); MARK (M. H.); CURRIE (L. J.); WOOTEN (G. F.); SAINT-HILAIRE (M.); WILK (J. B.); VOLCJAK (J.); MAHER (J. E.); FELDMAN (R. G.); GUTTMAN (M.); LEW (M.); SCHUMAN (S.); SUCHOWERSKY (O.); LAFONTAINE (A. L.); LABELLE (N.); VIEREGGE (P.); PRAMSTALLER (P. P.); KLEIN (C.); HUBBLE (J.); REIDER (C.); GROWDON (J.); WATTS (R.); MONTGOMERY (E.); BAKER (K.); SINGER (C.); STACY (M.); MYERS (R. H.)
AF : Department of Neurology, Boston University School of Medicine/MA/Etats-Unis; Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School/New Brunswick/Etats-Unis; Department of Neurology, University of Virginia Health System/Charlottesville/Etats-Unis; Division of Neurology, Department of Medicine, University of Toronto/Ontario/Canada; Department of Neurology, University of Southern California/Los Angeles/Etats-Unis; Departments of Clinical Neurosciences and Medical Genetics, University of Calgary/Alberta/Canada; Department of Neurology, Medical University of Lübeck/Allemagne; Department of Neurology, General Regional Hospital Bolzano/Italie; Department of Neurology, Ohio State University/Columbus/Etats-Unis; Department of Neurology Massachusetts General Hospital, Harvard Medical School/Boston/Etats-Unis; Department of Neurology, Emory University/Atlanta, GA/Etats-Unis; Departments of Neurology and Neuroscience, Cleveland Clinic Foundation/OH/Etats-Unis; Department of Neurology, University of Miami/FL/Etats-Unis; Department of Neurology, Barrow Clinic/Phoenix, AZ/Etats-Unis
DT : Publication en série; Niveau analytique
SO : Neurology; ISSN 0028-3878; Coden NEURAI; Etats-Unis; Da. 2002; Vol. 58; No. 1; Pp. 79-84; Bibl. 54 ref.
LA : Anglais
EA : Objective: To examine patterns of familial aggregation and factors influencing onset age in a sample of siblings with PD. Methods: Sibling pairs (n = 203) with PD were collected as part of the GenePD study. Standardized family history, medical history, and risk factor data were collected and analyzed. Results: The mean age at onset was 61.4 years and did not differ according to sex, exposure to coffee, alcohol, or pesticides. Head trauma was associated with younger onset (p = 0.03) and multivitamin use with later onset (p = 0.007). Age at onset correlation between sibling pairs was significant (r = 0.56, p = 0.001) and was larger than the correlation in year of onset (r = 0.29). The mean difference in onset age between siblings was 8.7 years (range, 0 to 30 years). Female sex was associated with increased frequency of relatives with PD. The frequency of affected parents (7.0%) and siblings (5.1%) was increased when compared with frequency in spouses (2.0%). Conclusions: The greater similarity for age at onset than for year of onset in sibling pairs with PD, together with increased risk for biological relatives over spouses of cases, supports a genetic component for PD. Risk to siblings in this series is increased over that seen in random series of PD cases; however, patients in this sample have similar ages at onset and sex distribution as seen for PD generally. These analyses suggest that factors influencing penetrance are critical to the understanding of this disease.
CC : 002B17G
FD : Parkinson maladie; Age apparition; Agrégation; Phénotype; Déterminisme génétique; Epidémiologie; Fratrie; Facteur risque; Homme
FG : Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Maladie héréditaire
ED : Parkinson disease; Age of onset; Aggregation; Phenotype; Genetic determinism; Epidemiology; Sibling; Risk factor; Human
EG : Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Genetic disease
SD : Parkinson enfermedad; Edad aparición; Agregación; Fenotipo; Determinismo genético; Epidemiología; Hermandad; Factor riesgo; Hombre
LO : INIST-6345.354000094698500120
ID : 02-0118878

Links to Exploration step

Pascal:02-0118878

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study</title>
<author>
<name sortKey="Maher, N E" sort="Maher, N E" uniqKey="Maher N" first="N. E." last="Maher">N. E. Maher</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Boston University School of Medicine</s1>
<s2>MA</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School</s1>
<s2>New Brunswick</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, University of Virginia Health System</s1>
<s2>Charlottesville</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Neurology, University of Southern California</s1>
<s2>Los Angeles</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="06">
<s1>Departments of Clinical Neurosciences and Medical Genetics, University of Calgary</s1>
<s2>Alberta</s2>
<s3>CAN</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Neurology, Medical University of Lübeck</s1>
<s3>DEU</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="08">
<s1>Department of Neurology, General Regional Hospital Bolzano</s1>
<s3>ITA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="09">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="10">
<s1>Department of Neurology Massachusetts General Hospital, Harvard Medical School</s1>
<s2>Boston</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="11">
<s1>Department of Neurology, Emory University</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="12">
<s1>Departments of Neurology and Neuroscience, Cleveland Clinic Foundation</s1>
<s2>OH</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="13">
<s1>Department of Neurology, University of Miami</s1>
<s2>FL</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="14">
<s1>Department of Neurology, Barrow Clinic</s1>
<s2>Phoenix, AZ</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Golbe, L I" sort="Golbe, L I" uniqKey="Golbe L" first="L. I." last="Golbe">L. I. Golbe</name>
</author>
<author>
<name sortKey="Lazzarini, A M" sort="Lazzarini, A M" uniqKey="Lazzarini A" first="A. M." last="Lazzarini">A. M. Lazzarini</name>
</author>
<author>
<name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M. H." last="Mark">M. H. Mark</name>
</author>
<author>
<name sortKey="Currie, L J" sort="Currie, L J" uniqKey="Currie L" first="L. J." last="Currie">L. J. Currie</name>
</author>
<author>
<name sortKey="Wooten, G F" sort="Wooten, G F" uniqKey="Wooten G" first="G. F." last="Wooten">G. F. Wooten</name>
</author>
<author>
<name sortKey="Saint Hilaire, M" sort="Saint Hilaire, M" uniqKey="Saint Hilaire M" first="M." last="Saint-Hilaire">M. Saint-Hilaire</name>
</author>
<author>
<name sortKey="Wilk, J B" sort="Wilk, J B" uniqKey="Wilk J" first="J. B." last="Wilk">J. B. Wilk</name>
</author>
<author>
<name sortKey="Volcjak, J" sort="Volcjak, J" uniqKey="Volcjak J" first="J." last="Volcjak">J. Volcjak</name>
</author>
<author>
<name sortKey="Maher, J E" sort="Maher, J E" uniqKey="Maher J" first="J. E." last="Maher">J. E. Maher</name>
</author>
<author>
<name sortKey="Feldman, R G" sort="Feldman, R G" uniqKey="Feldman R" first="R. G." last="Feldman">R. G. Feldman</name>
</author>
<author>
<name sortKey="Guttman, M" sort="Guttman, M" uniqKey="Guttman M" first="M." last="Guttman">M. Guttman</name>
</author>
<author>
<name sortKey="Lew, M" sort="Lew, M" uniqKey="Lew M" first="M." last="Lew">M. Lew</name>
</author>
<author>
<name sortKey="Schuman, S" sort="Schuman, S" uniqKey="Schuman S" first="S." last="Schuman">S. Schuman</name>
</author>
<author>
<name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O." last="Suchowersky">O. Suchowersky</name>
</author>
<author>
<name sortKey="Lafontaine, A L" sort="Lafontaine, A L" uniqKey="Lafontaine A" first="A. L." last="Lafontaine">A. L. Lafontaine</name>
</author>
<author>
<name sortKey="Labelle, N" sort="Labelle, N" uniqKey="Labelle N" first="N." last="Labelle">N. Labelle</name>
</author>
<author>
<name sortKey="Vieregge, P" sort="Vieregge, P" uniqKey="Vieregge P" first="P." last="Vieregge">P. Vieregge</name>
</author>
<author>
<name sortKey="Pramstaller, P P" sort="Pramstaller, P P" uniqKey="Pramstaller P" first="P. P." last="Pramstaller">P. P. Pramstaller</name>
</author>
<author>
<name sortKey="Klein, C" sort="Klein, C" uniqKey="Klein C" first="C." last="Klein">C. Klein</name>
</author>
<author>
<name sortKey="Hubble, J" sort="Hubble, J" uniqKey="Hubble J" first="J." last="Hubble">J. Hubble</name>
</author>
<author>
<name sortKey="Reider, C" sort="Reider, C" uniqKey="Reider C" first="C." last="Reider">C. Reider</name>
</author>
<author>
<name sortKey="Growdon, J" sort="Growdon, J" uniqKey="Growdon J" first="J." last="Growdon">J. Growdon</name>
</author>
<author>
<name sortKey="Watts, R" sort="Watts, R" uniqKey="Watts R" first="R." last="Watts">R. Watts</name>
</author>
<author>
<name sortKey="Montgomery, E" sort="Montgomery, E" uniqKey="Montgomery E" first="E." last="Montgomery">E. Montgomery</name>
</author>
<author>
<name sortKey="Baker, K" sort="Baker, K" uniqKey="Baker K" first="K." last="Baker">K. Baker</name>
</author>
<author>
<name sortKey="Singer, C" sort="Singer, C" uniqKey="Singer C" first="C." last="Singer">C. Singer</name>
</author>
<author>
<name sortKey="Stacy, M" sort="Stacy, M" uniqKey="Stacy M" first="M." last="Stacy">M. Stacy</name>
</author>
<author>
<name sortKey="Myers, R H" sort="Myers, R H" uniqKey="Myers R" first="R. H." last="Myers">R. H. Myers</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">02-0118878</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0118878 INIST</idno>
<idno type="RBID">Pascal:02-0118878</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C04</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study</title>
<author>
<name sortKey="Maher, N E" sort="Maher, N E" uniqKey="Maher N" first="N. E." last="Maher">N. E. Maher</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Neurology, Boston University School of Medicine</s1>
<s2>MA</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School</s1>
<s2>New Brunswick</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Neurology, University of Virginia Health System</s1>
<s2>Charlottesville</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="04">
<s1>Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="05">
<s1>Department of Neurology, University of Southern California</s1>
<s2>Los Angeles</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="06">
<s1>Departments of Clinical Neurosciences and Medical Genetics, University of Calgary</s1>
<s2>Alberta</s2>
<s3>CAN</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="07">
<s1>Department of Neurology, Medical University of Lübeck</s1>
<s3>DEU</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="08">
<s1>Department of Neurology, General Regional Hospital Bolzano</s1>
<s3>ITA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="09">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="10">
<s1>Department of Neurology Massachusetts General Hospital, Harvard Medical School</s1>
<s2>Boston</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="11">
<s1>Department of Neurology, Emory University</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="12">
<s1>Departments of Neurology and Neuroscience, Cleveland Clinic Foundation</s1>
<s2>OH</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="13">
<s1>Department of Neurology, University of Miami</s1>
<s2>FL</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="14">
<s1>Department of Neurology, Barrow Clinic</s1>
<s2>Phoenix, AZ</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Golbe, L I" sort="Golbe, L I" uniqKey="Golbe L" first="L. I." last="Golbe">L. I. Golbe</name>
</author>
<author>
<name sortKey="Lazzarini, A M" sort="Lazzarini, A M" uniqKey="Lazzarini A" first="A. M." last="Lazzarini">A. M. Lazzarini</name>
</author>
<author>
<name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M. H." last="Mark">M. H. Mark</name>
</author>
<author>
<name sortKey="Currie, L J" sort="Currie, L J" uniqKey="Currie L" first="L. J." last="Currie">L. J. Currie</name>
</author>
<author>
<name sortKey="Wooten, G F" sort="Wooten, G F" uniqKey="Wooten G" first="G. F." last="Wooten">G. F. Wooten</name>
</author>
<author>
<name sortKey="Saint Hilaire, M" sort="Saint Hilaire, M" uniqKey="Saint Hilaire M" first="M." last="Saint-Hilaire">M. Saint-Hilaire</name>
</author>
<author>
<name sortKey="Wilk, J B" sort="Wilk, J B" uniqKey="Wilk J" first="J. B." last="Wilk">J. B. Wilk</name>
</author>
<author>
<name sortKey="Volcjak, J" sort="Volcjak, J" uniqKey="Volcjak J" first="J." last="Volcjak">J. Volcjak</name>
</author>
<author>
<name sortKey="Maher, J E" sort="Maher, J E" uniqKey="Maher J" first="J. E." last="Maher">J. E. Maher</name>
</author>
<author>
<name sortKey="Feldman, R G" sort="Feldman, R G" uniqKey="Feldman R" first="R. G." last="Feldman">R. G. Feldman</name>
</author>
<author>
<name sortKey="Guttman, M" sort="Guttman, M" uniqKey="Guttman M" first="M." last="Guttman">M. Guttman</name>
</author>
<author>
<name sortKey="Lew, M" sort="Lew, M" uniqKey="Lew M" first="M." last="Lew">M. Lew</name>
</author>
<author>
<name sortKey="Schuman, S" sort="Schuman, S" uniqKey="Schuman S" first="S." last="Schuman">S. Schuman</name>
</author>
<author>
<name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O." last="Suchowersky">O. Suchowersky</name>
</author>
<author>
<name sortKey="Lafontaine, A L" sort="Lafontaine, A L" uniqKey="Lafontaine A" first="A. L." last="Lafontaine">A. L. Lafontaine</name>
</author>
<author>
<name sortKey="Labelle, N" sort="Labelle, N" uniqKey="Labelle N" first="N." last="Labelle">N. Labelle</name>
</author>
<author>
<name sortKey="Vieregge, P" sort="Vieregge, P" uniqKey="Vieregge P" first="P." last="Vieregge">P. Vieregge</name>
</author>
<author>
<name sortKey="Pramstaller, P P" sort="Pramstaller, P P" uniqKey="Pramstaller P" first="P. P." last="Pramstaller">P. P. Pramstaller</name>
</author>
<author>
<name sortKey="Klein, C" sort="Klein, C" uniqKey="Klein C" first="C." last="Klein">C. Klein</name>
</author>
<author>
<name sortKey="Hubble, J" sort="Hubble, J" uniqKey="Hubble J" first="J." last="Hubble">J. Hubble</name>
</author>
<author>
<name sortKey="Reider, C" sort="Reider, C" uniqKey="Reider C" first="C." last="Reider">C. Reider</name>
</author>
<author>
<name sortKey="Growdon, J" sort="Growdon, J" uniqKey="Growdon J" first="J." last="Growdon">J. Growdon</name>
</author>
<author>
<name sortKey="Watts, R" sort="Watts, R" uniqKey="Watts R" first="R." last="Watts">R. Watts</name>
</author>
<author>
<name sortKey="Montgomery, E" sort="Montgomery, E" uniqKey="Montgomery E" first="E." last="Montgomery">E. Montgomery</name>
</author>
<author>
<name sortKey="Baker, K" sort="Baker, K" uniqKey="Baker K" first="K." last="Baker">K. Baker</name>
</author>
<author>
<name sortKey="Singer, C" sort="Singer, C" uniqKey="Singer C" first="C." last="Singer">C. Singer</name>
</author>
<author>
<name sortKey="Stacy, M" sort="Stacy, M" uniqKey="Stacy M" first="M." last="Stacy">M. Stacy</name>
</author>
<author>
<name sortKey="Myers, R H" sort="Myers, R H" uniqKey="Myers R" first="R. H." last="Myers">R. H. Myers</name>
</author>
</analytic>
<series>
<title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Age of onset</term>
<term>Aggregation</term>
<term>Epidemiology</term>
<term>Genetic determinism</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Phenotype</term>
<term>Risk factor</term>
<term>Sibling</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Age apparition</term>
<term>Agrégation</term>
<term>Phénotype</term>
<term>Déterminisme génétique</term>
<term>Epidémiologie</term>
<term>Fratrie</term>
<term>Facteur risque</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Objective: To examine patterns of familial aggregation and factors influencing onset age in a sample of siblings with PD. Methods: Sibling pairs (n = 203) with PD were collected as part of the GenePD study. Standardized family history, medical history, and risk factor data were collected and analyzed. Results: The mean age at onset was 61.4 years and did not differ according to sex, exposure to coffee, alcohol, or pesticides. Head trauma was associated with younger onset (p = 0.03) and multivitamin use with later onset (p = 0.007). Age at onset correlation between sibling pairs was significant (r = 0.56, p = 0.001) and was larger than the correlation in year of onset (r = 0.29). The mean difference in onset age between siblings was 8.7 years (range, 0 to 30 years). Female sex was associated with increased frequency of relatives with PD. The frequency of affected parents (7.0%) and siblings (5.1%) was increased when compared with frequency in spouses (2.0%). Conclusions: The greater similarity for age at onset than for year of onset in sibling pairs with PD, together with increased risk for biological relatives over spouses of cases, supports a genetic component for PD. Risk to siblings in this series is increased over that seen in random series of PD cases; however, patients in this sample have similar ages at onset and sex distribution as seen for PD generally. These analyses suggest that factors influencing penetrance are critical to the understanding of this disease.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0028-3878</s0>
</fA01>
<fA02 i1="01">
<s0>NEURAI</s0>
</fA02>
<fA03 i2="1">
<s0>Neurology</s0>
</fA03>
<fA05>
<s2>58</s2>
</fA05>
<fA06>
<s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MAHER (N. E.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>GOLBE (L. I.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>LAZZARINI (A. M.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>MARK (M. H.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>CURRIE (L. J.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>WOOTEN (G. F.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>SAINT-HILAIRE (M.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>WILK (J. B.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>VOLCJAK (J.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>MAHER (J. E.)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>FELDMAN (R. G.)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>GUTTMAN (M.)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>LEW (M.)</s1>
</fA11>
<fA11 i1="14" i2="1">
<s1>SCHUMAN (S.)</s1>
</fA11>
<fA11 i1="15" i2="1">
<s1>SUCHOWERSKY (O.)</s1>
</fA11>
<fA11 i1="16" i2="1">
<s1>LAFONTAINE (A. L.)</s1>
</fA11>
<fA11 i1="17" i2="1">
<s1>LABELLE (N.)</s1>
</fA11>
<fA11 i1="18" i2="1">
<s1>VIEREGGE (P.)</s1>
</fA11>
<fA11 i1="19" i2="1">
<s1>PRAMSTALLER (P. P.)</s1>
</fA11>
<fA11 i1="20" i2="1">
<s1>KLEIN (C.)</s1>
</fA11>
<fA11 i1="21" i2="1">
<s1>HUBBLE (J.)</s1>
</fA11>
<fA11 i1="22" i2="1">
<s1>REIDER (C.)</s1>
</fA11>
<fA11 i1="23" i2="1">
<s1>GROWDON (J.)</s1>
</fA11>
<fA11 i1="24" i2="1">
<s1>WATTS (R.)</s1>
</fA11>
<fA11 i1="25" i2="1">
<s1>MONTGOMERY (E.)</s1>
</fA11>
<fA11 i1="26" i2="1">
<s1>BAKER (K.)</s1>
</fA11>
<fA11 i1="27" i2="1">
<s1>SINGER (C.)</s1>
</fA11>
<fA11 i1="28" i2="1">
<s1>STACY (M.)</s1>
</fA11>
<fA11 i1="29" i2="1">
<s1>MYERS (R. H.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Neurology, Boston University School of Medicine</s1>
<s2>MA</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="02">
<s1>Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School</s1>
<s2>New Brunswick</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="03">
<s1>Department of Neurology, University of Virginia Health System</s1>
<s2>Charlottesville</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="04">
<s1>Division of Neurology, Department of Medicine, University of Toronto</s1>
<s2>Ontario</s2>
<s3>CAN</s3>
</fA14>
<fA14 i1="05">
<s1>Department of Neurology, University of Southern California</s1>
<s2>Los Angeles</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="06">
<s1>Departments of Clinical Neurosciences and Medical Genetics, University of Calgary</s1>
<s2>Alberta</s2>
<s3>CAN</s3>
</fA14>
<fA14 i1="07">
<s1>Department of Neurology, Medical University of Lübeck</s1>
<s3>DEU</s3>
</fA14>
<fA14 i1="08">
<s1>Department of Neurology, General Regional Hospital Bolzano</s1>
<s3>ITA</s3>
</fA14>
<fA14 i1="09">
<s1>Department of Neurology, Ohio State University</s1>
<s2>Columbus</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="10">
<s1>Department of Neurology Massachusetts General Hospital, Harvard Medical School</s1>
<s2>Boston</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="11">
<s1>Department of Neurology, Emory University</s1>
<s2>Atlanta, GA</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="12">
<s1>Departments of Neurology and Neuroscience, Cleveland Clinic Foundation</s1>
<s2>OH</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="13">
<s1>Department of Neurology, University of Miami</s1>
<s2>FL</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="14">
<s1>Department of Neurology, Barrow Clinic</s1>
<s2>Phoenix, AZ</s2>
<s3>USA</s3>
</fA14>
<fA20>
<s1>79-84</s1>
</fA20>
<fA21>
<s1>2002</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>6345</s2>
<s5>354000094698500120</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2002 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>54 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>02-0118878</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Neurology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Objective: To examine patterns of familial aggregation and factors influencing onset age in a sample of siblings with PD. Methods: Sibling pairs (n = 203) with PD were collected as part of the GenePD study. Standardized family history, medical history, and risk factor data were collected and analyzed. Results: The mean age at onset was 61.4 years and did not differ according to sex, exposure to coffee, alcohol, or pesticides. Head trauma was associated with younger onset (p = 0.03) and multivitamin use with later onset (p = 0.007). Age at onset correlation between sibling pairs was significant (r = 0.56, p = 0.001) and was larger than the correlation in year of onset (r = 0.29). The mean difference in onset age between siblings was 8.7 years (range, 0 to 30 years). Female sex was associated with increased frequency of relatives with PD. The frequency of affected parents (7.0%) and siblings (5.1%) was increased when compared with frequency in spouses (2.0%). Conclusions: The greater similarity for age at onset than for year of onset in sibling pairs with PD, together with increased risk for biological relatives over spouses of cases, supports a genetic component for PD. Risk to siblings in this series is increased over that seen in random series of PD cases; however, patients in this sample have similar ages at onset and sex distribution as seen for PD generally. These analyses suggest that factors influencing penetrance are critical to the understanding of this disease.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Age apparition</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Age of onset</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Edad aparición</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Agrégation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Aggregation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Agregación</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Phénotype</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Phenotype</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Fenotipo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Déterminisme génétique</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Genetic determinism</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Determinismo genético</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Epidémiologie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Epidemiology</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Epidemiología</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Fratrie</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Sibling</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hermandad</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Facteur risque</s0>
<s5>19</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Risk factor</s0>
<s5>19</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Factor riesgo</s0>
<s5>19</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Maladie héréditaire</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Genetic disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Enfermedad hereditaria</s0>
<s5>42</s5>
</fC07>
<fN21>
<s1>063</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 02-0118878 INIST</NO>
<ET>Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study</ET>
<AU>MAHER (N. E.); GOLBE (L. I.); LAZZARINI (A. M.); MARK (M. H.); CURRIE (L. J.); WOOTEN (G. F.); SAINT-HILAIRE (M.); WILK (J. B.); VOLCJAK (J.); MAHER (J. E.); FELDMAN (R. G.); GUTTMAN (M.); LEW (M.); SCHUMAN (S.); SUCHOWERSKY (O.); LAFONTAINE (A. L.); LABELLE (N.); VIEREGGE (P.); PRAMSTALLER (P. P.); KLEIN (C.); HUBBLE (J.); REIDER (C.); GROWDON (J.); WATTS (R.); MONTGOMERY (E.); BAKER (K.); SINGER (C.); STACY (M.); MYERS (R. H.)</AU>
<AF>Department of Neurology, Boston University School of Medicine/MA/Etats-Unis; Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School/New Brunswick/Etats-Unis; Department of Neurology, University of Virginia Health System/Charlottesville/Etats-Unis; Division of Neurology, Department of Medicine, University of Toronto/Ontario/Canada; Department of Neurology, University of Southern California/Los Angeles/Etats-Unis; Departments of Clinical Neurosciences and Medical Genetics, University of Calgary/Alberta/Canada; Department of Neurology, Medical University of Lübeck/Allemagne; Department of Neurology, General Regional Hospital Bolzano/Italie; Department of Neurology, Ohio State University/Columbus/Etats-Unis; Department of Neurology Massachusetts General Hospital, Harvard Medical School/Boston/Etats-Unis; Department of Neurology, Emory University/Atlanta, GA/Etats-Unis; Departments of Neurology and Neuroscience, Cleveland Clinic Foundation/OH/Etats-Unis; Department of Neurology, University of Miami/FL/Etats-Unis; Department of Neurology, Barrow Clinic/Phoenix, AZ/Etats-Unis</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Neurology; ISSN 0028-3878; Coden NEURAI; Etats-Unis; Da. 2002; Vol. 58; No. 1; Pp. 79-84; Bibl. 54 ref.</SO>
<LA>Anglais</LA>
<EA>Objective: To examine patterns of familial aggregation and factors influencing onset age in a sample of siblings with PD. Methods: Sibling pairs (n = 203) with PD were collected as part of the GenePD study. Standardized family history, medical history, and risk factor data were collected and analyzed. Results: The mean age at onset was 61.4 years and did not differ according to sex, exposure to coffee, alcohol, or pesticides. Head trauma was associated with younger onset (p = 0.03) and multivitamin use with later onset (p = 0.007). Age at onset correlation between sibling pairs was significant (r = 0.56, p = 0.001) and was larger than the correlation in year of onset (r = 0.29). The mean difference in onset age between siblings was 8.7 years (range, 0 to 30 years). Female sex was associated with increased frequency of relatives with PD. The frequency of affected parents (7.0%) and siblings (5.1%) was increased when compared with frequency in spouses (2.0%). Conclusions: The greater similarity for age at onset than for year of onset in sibling pairs with PD, together with increased risk for biological relatives over spouses of cases, supports a genetic component for PD. Risk to siblings in this series is increased over that seen in random series of PD cases; however, patients in this sample have similar ages at onset and sex distribution as seen for PD generally. These analyses suggest that factors influencing penetrance are critical to the understanding of this disease.</EA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Age apparition; Agrégation; Phénotype; Déterminisme génétique; Epidémiologie; Fratrie; Facteur risque; Homme</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Maladie héréditaire</FG>
<ED>Parkinson disease; Age of onset; Aggregation; Phenotype; Genetic determinism; Epidemiology; Sibling; Risk factor; Human</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Genetic disease</EG>
<SD>Parkinson enfermedad; Edad aparición; Agregación; Fenotipo; Determinismo genético; Epidemiología; Hermandad; Factor riesgo; Hombre</SD>
<LO>INIST-6345.354000094698500120</LO>
<ID>02-0118878</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C04 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000C04 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:02-0118878
   |texte=   Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022